A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barr é Syndrome (GBS)
Condition: Guillain-Barré Syndrome Interventions: Drug: Crovalimab; Drug: Placebo; Drug: Intravenous immunoglobulin therapy Sponsors: Hoffmann-La Roche; Chugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials